These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20567176)

  • 1. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia.
    Costantine MM; Tamayo E; Lu F; Bytautiene E; Longo M; Hankins GDV; Saade GR
    Obstet Gynecol; 2010 Jul; 116(1):114-120. PubMed ID: 20567176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model.
    McDonnold M; Tamayo E; Kechichian T; Gamble P; Longo M; Hankins GD; Saade GR; Costantine MM
    Am J Obstet Gynecol; 2014 Jun; 210(6):542.e1-7. PubMed ID: 24412113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia.
    Saad AF; Diken ZM; Kechichian TB; Clark SM; Olson GL; Saade GR; Costantine MM
    Reprod Sci; 2016 Nov; 23(11):1593-1599. PubMed ID: 27170663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia.
    Fox KA; Longo M; Tamayo E; Kechichian T; Bytautiene E; Hankins GD; Saade GR; Costantine MM
    Am J Obstet Gynecol; 2011 Oct; 205(4):366.e1-5. PubMed ID: 22083058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model.
    Carver AR; Andrikopoulou M; Lei J; Tamayo E; Gamble P; Hou Z; Zhang J; Mori S; Saade GR; Costantine MM; Burd I
    PLoS One; 2014; 9(6):e100873. PubMed ID: 24963809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice.
    Lu F; Longo M; Tamayo E; Maner W; Al-Hendy A; Anderson GD; Hankins GD; Saade GR
    Am J Obstet Gynecol; 2007 Apr; 196(4):396.e1-7; discussion 396.e7. PubMed ID: 17403433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model.
    Byers BD; Betancourt A; Lu F; Hankins GD; Longo M; Saade GR; Bytautiene E
    Am J Obstet Gynecol; 2009 Apr; 200(4):432.e1-7. PubMed ID: 19318153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.
    Ahmed A; Williams DJ; Cheed V; Middleton LJ; Ahmad S; Wang K; Vince AT; Hewett P; Spencer K; Khan KS; Daniels JP;
    BJOG; 2020 Mar; 127(4):478-488. PubMed ID: 31715077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia.
    Bytautiene E; Lu F; Tamayo EH; Hankins GD; Longo M; Kublickiene K; Saade GR
    Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H189-93. PubMed ID: 19915174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1.
    Mateus J; Bytautiene E; Lu F; Tamayo EH; Betancourt A; Hankins GD; Longo M; Saade GR
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1781-7. PubMed ID: 21890691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction.
    de Alwis N; Beard S; Mangwiro YT; Binder NK; Kaitu'u-Lino TJ; Brownfoot FC; Tong S; Hannan NJ
    Pregnancy Hypertens; 2020 Apr; 20():83-91. PubMed ID: 32199147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.
    Suzuki H; Ohkuchi A; Matsubara S; Takei Y; Murakami M; Shibuya M; Suzuki M; Sato Y
    Hypertension; 2009 Nov; 54(5):1129-35. PubMed ID: 19786649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
    Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
    Chimini JS; Possomato-Vieira JS; da Silva MLS; Dias-Junior CA
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):385-393. PubMed ID: 30318719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.